Related references
Note: Only part of the references are listed.Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias
Kyle Denton et al.
HUMAN MOLECULAR GENETICS (2018)
Differential Expression of Several miRNA's and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients
Katarina Vrabec et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5
Cecilia Marelli et al.
BRAIN (2018)
Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial
Ludger Schoels et al.
BRAIN (2017)
Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism
Darius Ebrahimi-Fakhari et al.
BRAIN (2016)
Conserved pharmacological rescue of hereditary spastic paraplegia-related phenotypes across model organisms
Carl Julien et al.
HUMAN MOLECULAR GENETICS (2016)
Treatment of SPG5 with cholesterol-lowering drugs
Andrea Mignarri et al.
JOURNAL OF NEUROLOGY (2015)
Dalfampridine in hereditary spastic paraplegia: a prospective, open study
Matthieu Bereau et al.
JOURNAL OF NEUROLOGY (2015)
FUNCTIONAL EFFECTS OF BOTULINUM TOXIN TYPE-A TREATMENT AND SUBSEQUENT STRETCHING OF SPASTIC CALF MUSCLES: A STUDY IN PATIENTS WITH HEREDITARY SPASTIC PARAPLEGIA
Mark de Niet et al.
JOURNAL OF REHABILITATION MEDICINE (2015)
Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia
Hans Zempel et al.
MOLECULAR NEURODEGENERATION (2015)
Automated measurement of fast mitochondrial transport in neurons
Kyle E. Miller et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Robotic gait training improves motor skills and quality of life in hereditary spastic paraplegia
F. Bertolucci et al.
NEUROREHABILITATION (2015)
Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia
Konstantinos Margetis et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2014)
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany
Daniele Orsucci et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2014)
Cold temperature improves mobility and survival in Drosophila models of autosomal-dominant hereditary spastic paraplegia (AD-HSP)
Sally L. Baxter et al.
DISEASE MODELS & MECHANISMS (2014)
Fishing for causes and cures of motor neuron disorders
Shunmoogum A. Patten et al.
DISEASE MODELS & MECHANISMS (2014)
The effect of hydrotherapy treatment on gait characteristics of hereditary spastic paraparesis patients
Yanxin Zhang et al.
GAIT & POSTURE (2014)
Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients neurons
Steven Havlicek et al.
HUMAN MOLECULAR GENETICS (2014)
Liver disease in infancy caused by oxysterol 7α-hydroxylase deficiency: successful treatment with chenodeoxycholic acid
Dongling Dai et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
StartReact Restores Reaction Time in HSP: Evidence for Subcortical Release of a Motor Program
Jorik Nonnekes et al.
JOURNAL OF NEUROSCIENCE (2014)
Ophthalmic manifestations of inherited neurodegenerative disorders
Hannah M. Kersten et al.
NATURE REVIEWS NEUROLOGY (2014)
The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies
Luis Ruano et al.
NEUROEPIDEMIOLOGY (2014)
Low dose tubulin-binding drugs rescue peroxisome trafficking deficit in patient-derived stem cells in Hereditary Spastic Paraplegia
Yongjun Fan et al.
BIOLOGY OPEN (2014)
Novel SPG10 mutation associated with dysautonomia, spinal cord atrophy, and skin biopsy abnormality
N. Collongues et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
A spastic paraplegia mouse model reveals REEP1-dependent ER shaping
Christian Beetz et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment
Conceicao Bettencourt et al.
JOURNAL OF NEUROLOGY (2013)
Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP)
Kathrin N. Karle et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
A Hereditary Spastic Paraplegia Mouse Model Supports a Role of ZFYVE26/SPASTIZIN for the Endolysosomal System
Mukhran Khundadze et al.
PLOS GENETICS (2013)
Mutations in DDHD2, Encoding an Intracellular Phospholipase A1, Cause a Recessive Form of Complex Hereditary Spastic Paraplegia
Janneke H. M. Schuurs-Hoeijmakers et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy
Stephan Klebe et al.
BRAIN (2012)
Spg20-/- mice reveal multimodal functions for Troyer syndrome protein spartin in lipid droplet maintenance, cytokinesis and BMP signaling
Benoit Renvoise et al.
HUMAN MOLECULAR GENETICS (2012)
Transcriptional and Post-Transcriptional Regulation of SPAST, the Gene Most Frequently Mutated in Hereditary Spastic Paraplegia
Brian J. Henson et al.
PLOS ONE (2012)
Comparison between the spastic paraplegia rating scale, Kurtzke scale, and Osame scale in the tropical spastic paraparesis/myelopathy associated with HTLV
Rodrigo Antonio Rocha da Cruz Adry et al.
Revista da Sociedade Brasileira de Medicina Tropical (2012)
Novel Mutations in SPG11 Cause Hereditary Spastic Paraplegia Associated with Early-Onset Levodopa-Responsive Parkinsonism
Arianna Guidubaldi et al.
MOVEMENT DISORDERS (2011)
Targeted disruption of the Mast syndrome gene SPG21 in mice impairs hind limb function and alters axon branching in cultured cortical neurons
Cynthia Soderblom et al.
NEUROGENETICS (2010)
Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study
Anne Kjersti Erichsen et al.
BRAIN (2009)
Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study
Chiara Criscuolo et al.
JOURNAL OF NEUROLOGY (2009)
Proton magnetic resonance spectroscopy and cognition in patients with spastin mutations
A. K. Erichsen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31
Christian Beetz et al.
BRAIN (2008)
SPG11 compound mutations in spastic paraparesis with thin corpus callosum
L. Samaranch et al.
NEUROLOGY (2008)
Motor and somatosensory evoked potentials in autosomal dominant hereditary spastic paraparesis (ADHSP) linked to chromosome 2p, SPG4
F. Sartucci et al.
BRAIN RESEARCH BULLETIN (2007)
Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia
K. H. Scheuer et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition
Anne Tarrade et al.
HUMAN MOLECULAR GENETICS (2006)
Methylphenidate fails to improve gait and muscle tone in patients with sporadic and hereditary spastic paraplegia
Stephan Klebe et al.
MOVEMENT DISORDERS (2006)
The Spastic Paraplegia Rating Scale (SPRS) -: A reliable and valid measure of disease severity
R. Schuele et al.
NEUROLOGY (2006)
Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia
M Pirozzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Inter- and intrastrain variation in mouse critical running speed
VL Billat et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport
F Ferreirinha et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Measuring the impact of MS on walking ability - The 12-Item MS Walking Scale (MSWS-12)
JC Hobart et al.
NEUROLOGY (2003)
Use of the Multiple Sclerosis Functional Composite as an outcome measure in a phase 3 clinical trial
JA Cohen et al.
ARCHIVES OF NEUROLOGY (2001)
Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment
P Rossier et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2001)
Share Paper
